Business
1 read
Trump's New Tariff on Brand Name Drugs Could Impact U.S. Investments

Want the full story?
Read the complete article at KTSM
AI Summary
President Trump has enacted a significant tariff of 100% on brand name pharmaceuticals, a move that is expected to raise costs for consumers and could threaten billions of dollars in investments made in the U.S. over the past year. This decision is part of a broader strategy to reshape trade policies but raises concerns about its potential economic repercussions. Stakeholders in the pharmaceutical industry and investors are particularly affected, as this could alter market dynamics and pricing structures.
economy trade investments tariff pharmaceuticals
People & Organizations
Donald Trump